Germany · Delayed Price · Currency is EUR Pharvaris Statistics
Total Valuation
Pharvaris has a market cap or net worth of EUR 1.45 billion. The enterprise value is 1.12 billion.
| Market Cap | 1.45B |
| Enterprise Value | 1.12B |
Important Dates
The last earnings date was Thursday, November 20, 2025.
| Earnings Date | Nov 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 64.96M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +9.65% |
| Shares Change (QoQ) | +13.84% |
| Owned by Insiders (%) | 5.24% |
| Owned by Institutions (%) | 51.69% |
| Float | 33.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 4.65 |
| P/TBV Ratio | 4.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.85 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.34 |
Financial Position
The company has a current ratio of 12.86, with a Debt / Equity ratio of 0.00.
| Current Ratio | 12.86 |
| Quick Ratio | 12.67 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.00 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.76% and return on invested capital (ROIC) is -34.30%.
| Return on Equity (ROE) | -53.76% |
| Return on Assets (ROA) | -32.07% |
| Return on Invested Capital (ROIC) | -34.30% |
| Return on Capital Employed (ROCE) | -53.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 108 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Pharvaris has paid 1.56 million in taxes.
| Income Tax | 1.56M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.86% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +6.86% |
| 50-Day Moving Average | 20.17 |
| 200-Day Moving Average | 16.94 |
| Relative Strength Index (RSI) | 67.86 |
| Average Volume (20 Days) | 2 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.76 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -167.32M |
| Pretax Income | -162.16M |
| Net Income | -163.72M |
| EBITDA | -167.26M |
| EBIT | -167.32M |
| Earnings Per Share (EPS) | -2.90 |
Balance Sheet
The company has 329.29 million in cash and 578,657 in debt, giving a net cash position of 328.71 million.
| Cash & Cash Equivalents | 329.29M |
| Total Debt | 578,657 |
| Net Cash | 328.71M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 312.24M |
| Book Value Per Share | 4.81 |
| Working Capital | 310.97M |
Cash Flow
In the last 12 months, operating cash flow was -134.07 million and capital expenditures -323,998, giving a free cash flow of -134.40 million.
| Operating Cash Flow | -134.07M |
| Capital Expenditures | -323,998 |
| Free Cash Flow | -134.40M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Pharvaris does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.65% |
| Shareholder Yield | -9.65% |
| Earnings Yield | -11.27% |
| FCF Yield | -9.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |